• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用免疫刺激剂增强疱疹疫苗的免疫原性]

[The use of immunostimulants for enhancing the immunogenicity of a herpes vaccine].

作者信息

Barinskiĭ I F, Semenova T B, Posevaia T A, Alimbarova L M, Kolieva M Kh, Shabalina N V

出版信息

Vopr Virusol. 1993 Nov-Dec;38(6):274-6.

PMID:8303890
Abstract

National immunostimulators and interferon inducers (poludan, ridostin, larifan, myelopide, vegetan) in combination with a commercial herpes vaccine (HV) were used for experimental immunization of mice. A 3-fold or greater rise of specific antibody titres was observed after a single immunization of intact BALB/c mice. In experiments in chronically infected animals a single inoculation of HV resulted in a 3-fold rise of specific antibody titres at 6 days postimmunization but not in later periods (20, 30 days). Administration of larifan, an interferon inducer, but not the immunostimulator myelopide, induced a synergic effect in these experiments. Activation of alpha-interferon production was observed early after combined use of HV and immunostimulators. It is concluded that combined experimental use of HV and immunostimulators activated both specific antibody production and interferon production.

摘要

将国家免疫刺激剂和干扰素诱导剂(聚多糖、瑞多斯汀、拉里凡、髓必妥、植物聚糖)与一种商用疱疹疫苗(HV)联合用于小鼠的实验性免疫。完整的BALB/c小鼠单次免疫后,观察到特异性抗体滴度有3倍或更高的升高。在慢性感染动物的实验中,单次接种HV后,免疫后6天特异性抗体滴度升高了3倍,但在后期(20天、30天)则没有。在这些实验中,干扰素诱导剂拉里凡的给药诱导了协同效应,而免疫刺激剂髓必妥则没有。在联合使用HV和免疫刺激剂后,早期观察到α干扰素产生的激活。得出的结论是,HV和免疫刺激剂的联合实验使用激活了特异性抗体产生和干扰素产生。

相似文献

1
[The use of immunostimulants for enhancing the immunogenicity of a herpes vaccine].[使用免疫刺激剂增强疱疹疫苗的免疫原性]
Vopr Virusol. 1993 Nov-Dec;38(6):274-6.
2
[Protective effect of a commercial vaccine, poludan and their combinations in an experimental herpes infection].[一种商业疫苗、Poludan及其组合在实验性疱疹感染中的保护作用]
Zh Mikrobiol Epidemiol Immunobiol. 1987 Feb(2):51-4.
3
[A killed commercial vaccine against herpes simplex viruses 1 and 2 as an immunocorrective agent in chronic herpetic infection].[一种针对单纯疱疹病毒1型和2型的灭活商业疫苗作为慢性疱疹感染的免疫纠正剂]
Zh Mikrobiol Epidemiol Immunobiol. 1999 Nov-Dec(6):98-102.
4
[Efficacy of herpetic vaccine, larifan, myelopid and their combinations during herpesvirus infection in irradiated animals].
Vopr Virusol. 1996 Nov-Dec;41(6):270-4.
5
Large scale comparison of adjuvant effects on immunogenicity and protection in a herpes simplex virus type 1 vaccination model.1型单纯疱疹病毒疫苗接种模型中佐剂对免疫原性和保护作用的大规模比较
Biochem Soc Trans. 1997 May;25(2):272S. doi: 10.1042/bst025272s.
6
Humoral response to HSV-1 subunit vaccines--a statistical analysis.对单纯疱疹病毒1型亚单位疫苗的体液免疫反应——一项统计分析。
Dev Biol Stand. 1998;92:335-40.
7
[Immunostimulating effect of interferon inducers].
Vopr Virusol. 1983 Jul-Aug;28(4):74-9.
8
Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.1型单纯疱疹病毒包膜亚单位疫苗不仅能抵御致死性病毒攻击,还可能限制病毒潜伏和再激活。
Acta Virol. 1995 Feb;39(1):37-49.
9
[The experimental efficacy of vaccination with a recombinant yeast vaccine against hepatitis B in combination with immunomodulators].[重组酵母乙型肝炎疫苗联合免疫调节剂接种的实验疗效]
Vopr Virusol. 1994 Jan-Feb;39(1):21-4.
10
Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.口服表达单纯疱疹病毒(HSV)抗原的重组鼠伤寒沙门氏菌疫苗株后对1型单纯疱疹病毒的保护性免疫。
J Gen Virol. 1997 Feb;78 ( Pt 2):427-34. doi: 10.1099/0022-1317-78-2-427.